Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001192482-20-000820

Chief Commercial Officer bought 171 shares at $2.28 ($390)

From the SEC's structured data for this filing

Trades in this filing

Harrell James Archie Jr · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-12-10 Purchase : show line 1 in the form +171 $2.28 $390 28,180 D
Open-market purchases · 171 sh · avg $2.28 · $390
Loading xslF345X03/edgar.xml…